Lucy Wang
Co-Founder and General Partner @ Divergent Capital
New York, United States
Lucy Wang is a seed investor at Divergent Capital in New York focused on Biotechnology. Lucy is a technologist & visionary at heart. A first generation immigrant, she moved to the US at 12YO and was brought up by a biomedical engineer and a material scientist. She started building at a young age, helping her father build a carbon fiber bike at 7YO that won an international award in Paris and publishing her work on nanoparticleresearch for cancer drug delivery while in high school.After graduating with a Mathematics degree from Brown University, Lucy started her career as an Investment Associate at Bridgewater on the research team working directly with Ray Dalio. It was there that she realized the power that can be harnessed from data with advanced techniques.She then pursued a Master's in Machine Learning at NYU Courant, studying under respected researchers including Yann Lecun and Kyunghun Cho. Her work there included building multimodal models & attention mechanisms, both critical stepping stones for LLMs.Lucy spent the last 10 years as an institutional investor and operator. She helped launch two computational startups: Livepeer, a peer to peer video transcoding network built on ethereum; and Rendered AI, a synthetic data platform for machine learning applications. She got her start in VC at Greycroft, working directly with the legendary Alan Patricof, a founding father of the industry. She later joined 11.2 Capital, leading deep tech investments in software and hardware.As a first check investor, 20% of her investments have become unicorns. Breakouts include Covariant AI, Immuta, and Clay.
- Total investments:
- 1
- Last investment:
- Lead investor:
- 100%
Last updated:
For AI agents: llms.txt
Industries Lucy Wang invests in
Stages Lucy Wang invests in
Countries Lucy Wang invests in
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Wayfinder Biosciences
|
Wayfinder Biosciences is a biotechnology company developing orally available small molecule drugs that modulate the function of the RNAs encoding key disease targets. The company's proprietary platform combines unique screening and computational technologies to rapidly discover potent, selective and biologically active RNA-targeting smallmolecules. Wayfinder's programs are focused on traditionally inaccessible targets in oncology and neurodegenerative disease. Wayfinder Biosciences was established in 2021 and is headquartered in Seattle, WA. | $3.6M / Seed / Oct 17, 2022 |
Co-Investors
BoxOne Ventures
1 deal together
Conscience VC
1 deal together
Genesis Consortium
1 deal together
Notation Capital
1 deal together
Notley
1 deal together
Overlap Holdings
1 deal together
About Divergent Capital
Divergent Capital is a venture capital firm providing financial services. It is a private equity financing that is provided by venture capital firms or funds to startups, early-stage, and emerging companies that have been deemed to have high growth potential or which have demonstrated high growth.
Divergent Capital Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Katie Shea
Co-Founder & Managing Partner
|
|||
|
Lucy Wang
Co-Founder and General Partner
|
|||
3 more contacts available
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does Lucy Wang invest in?
Lucy Wang invests primarily in Biotechnology startups, most often at Seed stage. Most of the 1 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Lucy Wang last invest?
The most recent investment recorded for Lucy Wang closed in Oct 2022. Shizune tracks 1 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
